LEADER 04575nam 22006735 450 001 9910300229603321 005 20200703091646.0 010 $a88-470-5711-6 024 7 $a10.1007/978-88-470-5711-1 035 $a(CKB)3710000000359183 035 $a(EBL)1974502 035 $a(SSID)ssj0001451751 035 $a(PQKBManifestationID)11896621 035 $a(PQKBTitleCode)TC0001451751 035 $a(PQKBWorkID)11479464 035 $a(PQKB)10732987 035 $a(DE-He213)978-88-470-5711-1 035 $a(MiAaPQ)EBC1974502 035 $a(PPN)184499046 035 $a(EXLCZ)993710000000359183 100 $a20150214d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aTreatment of Peritoneal Surface Malignancies $eState of the Art and Perspectives /$fedited by Angelo Di Giorgio, Enrico Pinto 205 $a1st ed. 2015. 210 1$aMilano :$cSpringer Milan :$cImprint: Springer,$d2015. 215 $a1 online resource (398 p.) 225 1 $aUpdates in Surgery,$x2280-9848 300 $aDescription based upon print version of record. 311 $a88-470-5710-8 320 $aIncludes bibliographical references at the end of each chapters. 327 $aForeword -- Preface 1 -- Preface 2 -- Introduction -- Part 1 Background -- 1 Peritoneal surface malignancies: definition -- 2 Epidemiology: the extent of the problem -- 3: Intraperitoneal spread: origin and mechanisms -- 4 Pathology and patterns of molecular biology -- 5 Classification of intraperitoneal spread -- 6 Diagnosis and assessment: clinical, radiological, and laparoscopic -- Part 2 Treatment -- 7 Rationale for integrated procedures (combined cytoreduction and HIPEC) -- 8 Peritonectomy techniques -- 9 HIPEC techniques -- 10 The role of surgery -- 11 The role of systemic chemotherapy -- 12 Anesthesiology and perioperative management -- 13 Patient selection for treatment -- 14 Morbidity and mortality -- 15 Organizational problems, costs, and data collection -- Part 3 Results of integrated treatment -- 16 Pseudomyxoma peritonei -- 17 Peritoneal mesothelioma -- 18  Peritoneal carcinomatosis from gastric cancer -- 19  Peritoneal carcinomatosis from colorectal cancer -- 20  Peritoneal carcinomatosis from ovarian and gynecological cancers -- 21 Other primary peritoneal surface malignancies -- 22  Peritoneal carcinomatosis from other primary tumors -- 23 Palliative treatments -- Part 4 Perspectives -- 24 New trials -- 25 Main topics of discussion and new trends -- Part 5 Conclusions. 330 $aThis monograph summarizes state of the art knowledge regarding peritoneal surface malignancies, with in-depth description of treatment options and the results achieved to date. It explores the most challenging problems on the basis of the authors? very extensive clinical experience and examines the most relevant clinical trials. A comprehensive summary is provided of all phase 2 studies (the only available completed studies) and of ongoing and future phase 3 studies. Particular attention is paid to the results of integrated treatment comprising cytoreduction (peritonectomy) and hyperthermic intraperitoneal chemotherapy (HIPEC). Helpful background information is also included on the definition and clinical assessment of each clinical form. The book, drawing on data from the entire Italian experience as well as world literature, will be an outstanding benchmark for health professionals and researchers. 410 0$aUpdates in Surgery,$x2280-9848 606 $aSurgical oncology 606 $aAbdominal surgery 606 $aPharmacotherapy 606 $aSurgical Oncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H59150 606 $aAbdominal Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H5901X 606 $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000 615 0$aSurgical oncology. 615 0$aAbdominal surgery. 615 0$aPharmacotherapy. 615 14$aSurgical Oncology. 615 24$aAbdominal Surgery. 615 24$aPharmacotherapy. 676 $a616.97438 702 $aDi Giorgio$b Angelo$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aPinto$b Enrico$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910300229603321 996 $aTreatment of Peritoneal Surface Malignancies$91763347 997 $aUNINA